Weight Loss (WL) With Low-Dose, Controlled-Release Phentermine/Topiramate (PHEN/TPM CR) Correlates With Improvements in Liver Function in Overweight/Obese Adults With Elevated Alanine Aminotransferase (ALT)

被引：0

|

作者：

Klein, Samuel

Najarian, Thomas

Troupin, Barbara

Day, Wesley W.

机构：

来源：

OBESITY | 2011年 / 19卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：S177 / S177

页数：1

相关论文

共 37 条

[31] Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial
Gadde, Kishore M.
Allison, David B.
Ryan, Donna H.
Peterson, Craig A.
Troupin, Barbara
Schwiers, Michael L.
Day, Wesley W.
LANCET, 2011, 377 (9774): : 1341 - 1352
[32] CONTROLLED-RELEASE LOW-DOSE PHENTERMINE/TOPIRAMATE (PHEN/TPM CR) REDUCES WEIGHT, IMPROVES GLYCEMIC MARKERS, AND DECREASES PROGRESSION TO TYPE 2 DIABETES MELLITUS (T2DM) IN OVERWEIGHT AND OBESE PATIENTS WITH OBESITY-RELATED COMORBIDITIES.
Troupin, B.
Hankin, C. S.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 : S38 - S38
[33] Once-Daily, Low-Dose, Controlled-Release Phentermine/Topiramate Demonstrates Significant Improvement in Weight, Related Risk in Overweight/Obese Patients with Comorbidities.
Garvey, W. T.
Bowden, C. H.
Day, W. W.
ENDOCRINE REVIEWS, 2010, 31 (03)
[34] Significant Weight Loss With Controlled-Release Phentermine/Topiramate (PHEN/TPM CR) Is Associated With Significant Reductions in Use of Concomitant Medications For Cardiometabolic Diseases Over 108 Weeks
Garvey, W. Timothy
Najarian, Thomas
Peterson, Craig A.
OBESITY, 2011, 19 : S176 - S176
[35] Diabetes Prevention and Normalization of Fasting Glucose in Subjects with Prediabetes Using Controlled-Release Phentermine/Topiramate (PHEN/TPM CR) in a 2-Year Weight Loss Intervention
Ryan, Donna H.
Garvey, Timothy
Troupin, Barbara
Day, Wesley W.
DIABETES, 2011, 60 : A509 - A509
[36] Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial (vol 377, pg 1341, 2011)
Gadde, K. M.
Allison, D. B.
Ryan, D. H.
LANCET, 2011, 377 (9776): : 1494 - 1494
[37] Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study
Garvey, W. Timothy
Ryan, Donna H.
Look, Michelle
Gadde, Kishore M.
Allison, David B.
Peterson, Craig A.
Schwiers, Michael
Day, Wesley W.
Bowden, Charles H.
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2012, 95 (02): : 297 - 308

← 1 2 3 4 →